Advertisement

Topics

Merck & Co Company Profile

07:57 EST 23rd November 2017 | BioPortfolio

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. We highlight the company's key figures. We explain the history of the name "Merck" and the two companies operating under this name today. We show Merck's visions for the future and guide you through over three hundred years of company history.

Location

Frankfurter Str. 250
Darmstadt
64293
Germany

Contact

Phone: +49 6151 72-0
Fax: +49 6151 72 2000
Email: webmaster@merck.de


News Articles [987 Associated News Articles listed on BioPortfolio]

Pharma Q3 Results Preview: Merck & Co., Merck KGaA

Investors will be eager to hear updates on Merck & Co.'s Keytruda market share versus other PD-1/L1 competitors in lung...   

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

Executive Board Changes at Merck

The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017. Walter Galinat (61) will hand over...

Merck erzielt Pharma-Erfolg mit neuer Tablette: Die EU hat das Medikament Cladribin von Merck zugelassen. ...

Die EU hat das Medikament Cladribin von Merck zugelassen. Es soll das erste Mittel gegen Multiple Sklerose sein, das oral verabreicht wird. Für die schwächelnde Merck-Sparte ist die Zulassung ein g....

STAT Plus: Merck lays off 1,800 U.S. sales rep to overhaul its primary care marketing

A Merck spokeswoman confirmed the move, which was disclosed to Merck employees on Thursday and is expected to be completed by early January.

STAT Plus: Merck lays off 1,800 U.S. sales reps to overhaul its primary care marketing

A Merck spokeswoman confirmed the move, which was disclosed to Merck employees on Thursday and is expected to be completed by early January.

Merck Moves Lower After Stopping Development Of Hepatitis C Treatments

KENILWORTH (NJ) (dpa-AFX) - Shares of Merck (MRK) are seeing notable weakness in afternoon trading on Friday, sliding by 1.1 percent. Merck is on pace to end the session at its lowest closing leve...

Merck Ventures adds to series A investment in Macrophage Pharma

Merck Ventures, the venture capital arm of the German pharmaceutical group Merck KGaA has invested in…

PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

Merck KGaA, F-Star shake on immune-oncology bispecifics.

Reactivation of Herpes Zoster Keratitis With Corneal Perforation After Zoster Vaccination.

We present a case of reactivated herpes zoster keratouveitis of 6 years duration with corneal perforation requiring penetrating keratoplasty shortly after inoculation with herpes zoster vaccine (Zosta...

Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling.

Merck & Co., Inc. (Kenilworth, New Jersey) has recently published an integrated strategy for implementation of dried blood spots (DBS) in late-stage trials for population pharmacokinetic (PK) modeling...

CHEMGENIE: integration of chemogenomics data for applications in chemical biology.

Increasing amounts of biological data are accumulating in the pharmaceutical industry and academic institutions. However, data do not equal actionable information, and guidelines for appropriate data ...

Avelumab: First Global Approval.

Avelumab (Bavencio(®)) is an intravenously administered programmed cell death ligand-1-blocking human antibody initially developed by EMD Serono Inc. (the biopharmaceutical division of Merck KGaA, Da...

Clinical Trials [76 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

The purpose of this study is to support licensure of GSK Biologicals' MMR vaccine (Priorix®) in the US by generating immunogenicity and safety data in contrast to the US standard of care,...

Immunogenicity of GSK Bio's HPV Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

HPV infection has been established as a necessary cause of cervical cancer. GSK Biologicals has developed an HPV-16/18 L1 VLP AS04 vaccine which targets the 2 most common oncogenic HPV typ...

Companies [135 Associated Companies listed on BioPortfolio]

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global ...

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

More Information about "Merck & Co" on BioPortfolio

We have published hundreds of Merck & Co news stories on BioPortfolio along with dozens of Merck & Co Clinical Trials and PubMed Articles about Merck & Co for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck & Co Companies in our database. You can also find out about relevant Merck & Co Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record